Clinical trial
Phase 2 Study of The Beta Cell Responsiveness to GIP With and Without Sulfonylurea in Patients With Type 2 Diabetes
NCT00321321 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of The Beta Cell Responsiveness to GIP With and Without Sulfonylurea in Patients With Type 2 Diabetes
- Lead sponsor
- University Hospital, Gentofte, Copenhagen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- April 30, 2007
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.